The transcription factor PU.1 is critical for viability and function of human brain microglia

GLIA

Volumn 61, Issue 6, 2013, Pages 929-942

  Smith, Amy M ^a   Gibbons, Hannah M ^a   Oldfield, Robyn L ^b   Bergin, Peter M ^a,c   Mee, Edward W ^a,c   Faull, Richard L M ^a   Dragunow, Mike ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Epilepsy; Human glial culture; Microglial activation; Phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; COMPLEMENTARY DNA; OLIGONUCLEOTIDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1;

ARTICLE; BRAIN CELL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IN VITRO STUDY; MICROGLIA; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BRAIN; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MICROGLIA; PHAGOCYTOSIS; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS;

EID: 84876488443     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22486     Document Type: Article

References (57)

1. Anderson KL, Nelson SL, Perkin HB, Smith KA, Klemsz MJ, Torbett BE. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J Biol Chem 2001;276:7637-7642.
2. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett BE. Myeloid development is selectively disrupted in PU.1 null mice. Blood 1998;91:3702-3710.
3. Back J, Allman D, Chan S, Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp Hematol 2005;33:395-402.
4. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000;6:916-919.
5. Barlic J, McDermott DH, Merrell MN, Gonzales J, Via LE, Murphy PM. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. J Biol Chem 2004;279:48520-48534.
6. Berclaz P, Zsengeller Z, Shibata Y, Otake K, Strasbaugh S, Whitsett J, Trapnell B. Endocytic internalisation of adenovirus, nonspecifc phagocytosis and cytoskeletal organisation are coordinately regulated in alveolar macrophages by GM-CSF and PU.1. J Immunol 2002;169:6332-6342.
7. Boche D, Denham N, Holmes C, Nicoll JAR. Neuropathology after active A beta 42 immunotherapy: Implications for Alzheimer's disease pathogenesis. Acta Neuropathol 2010;120:369-384.
8. Cai DH, Wang D, Keefer J, Yeamans C, Hensley K, Friedman AD. C/EBPa:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBPa homodimers or AP-1. Oncogene 2007;27:2772-2779.
9. Chen HM, Raygallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang DE, Moreaugachelin F, Tenen DG. PU.1 (SPI-1) autoregulates its expression in myeloid cells. Oncogene 1995;11:1549-1560.
10. Chen S-K, Tvrdik P, Peden E, Cho S, Wu S, Spangrude G, Capecchi MR. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2008;141:775-785.
11. Cunningham C. Microglia and neurodegeneration: The role of systemic inflammation. Glia 2012;61:71-90.
12. Davis MM. Immunology taught by humans. Sci Transl Med 2012;4:117.
13. Dragunow M. The adult human brain in preclinical drug development. Nat Rev 2008;7:659-666.
14. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot M-C, Bar-Or A, Antel JP. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012;60:717-727.
15. Ebralidze AK, Guibal FC, Steidl U, Zhang P, Lee S, Bartholdy B, Jorda MA, Petkova V, Rosenbauer F, Huang G, Dayaram T, Klupp J, O'Brien KB, Will B, Hoogenkamp M, Borden KLB, Bonifer C, Tenen DG. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev 2008;22:2085-2092.
16. Ellis SL, Gysbers V, Manders PM, Li W, Hofer MJ, Muller M, Campbell IL. The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. J Immunol 2010;185:1864-1877.
17. Feng R, Desbordes SC, Xie HF, Tillo ES, Pixley F, Stanley ER, Graf T. PU.1 and C/EBP alpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA 2008;105:6057-6062.
18. Forsberg M, Carlen M, Meletis K, Yeung MSY, Barnabe-Heider F, Persson MAA, Aarum J, Frisen J. Efficient reprogramming of adult neural stem cells to monocytes by ectopic expression of a single gene. Proc Natl Acad Sci USA 2010;107:14657-14661.
19. Fukai T, Nishiyama C, Kanada S, Nakano N, Hara M, Tokura T, Ikeda S, Ogawa H, Okumura K. Involvement of PU.1 in the transcriptional regulation of TNF-alpha. Biochem Biophys Res Commun 2009;388:102-106.
20. Garin A, Pellet P, Deterre P, Debre P, Combadiere C. Cloning and functional characterization of the human fractalkine receptor promoter regions. Biochem J 2002;368:753-760.
21. Ghani S, Riemke P, Schonheit J, Lenze D, Stumm J, Hoogenkamp M, Lagendijk A, Heinz S, Bonifer C, Bakkers J, Abdelilah-Seyfried S, Hummel M, Rosenbauer F. Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood 2011;118:2275-2284.
22. Gibbons HM, Dragunow M. Adult human brain cell culture for neuroscience research. Int J Biochem Cell Biol 2010;42:844-856.
23. Gibbons HM, Hughes SM, Van Roon-Mom W, Greenwood JM, Narayan PJ, Teoh HH, Bergin PM, Mee EW, Wood PC, Faull RLM, Dragunow M. Cellular composition of human glial cultures from adult biopsy brain tissue. J Neurosci Methods 2007;166:89-98.
24. Gibbons HM, Smith AM, Teoh HH, Bergin PM, Mee EW, Faull RLM, Dragunow M. Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures. Neurobiol Dis 2011;41:96-103.
25. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841-845.
26. Graeber MB. Changing face of microglia. Science 2010;330:783-788.
27. Hanisch U-K, Kettenmann H. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007;10:1387-1394.
28. Henkel GW, McKercher SR, Maki RA. Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells. Int Immunol 2002;14:723-732.
29. Huizinga R, van der Star BJ, Kipp M, Jong R, Gerritsen W, Clarner T, Puentes F, Dijkstra CD, van der Valk P, Amor S. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 2012;60:422-431.
30. Klegeris A, McGeer EG, McGeer PL. Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol 2007;20:351-357.
31. Koyama N, Hoelzer D, Ottmann OG. Regulation of human IL-18 gene expression: Interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cells. Eur J Immunol 2004;34:817-826.
32. Kummalue T, Friedman AD. Cross-talk between regulators of myeloid development: C/EBPa binds and activates the promoter of the PU.1 gene. J Leuk Biol 2003;74:464-470.
33. Leddin M, Perrod C, Hoogenkamp M, Ghani S, Assi S, Heinz S, Wilson NK, Follows G, Schonheit J, Vockentanz L, Mosammam AM, Chen W, Tenen DG, Westhead DR, Gottgens B, Bonifer C, Rosenbauer F. Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 2011;117:2827-2838.
34. Lloberas J, Soler C, Celada A. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol Today 1999;20:184-189.
35. Lynch AM, Murphy KJ, Deighan BF, O'Reilly JA, Gun'ko YK, Cowley TR, Gonzalez-Reyes RE, Lynch MA. The impact of glial activation in the aging brain. Aging Dis 2010;1:262-278.
36. MacGibbon GA, Lawlor PA, Walton M, Sirimanne E, Faull RLM, Synek B, Mee E, Connor B, Dragunow M. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol 1997;147:316-332.
37. Monzo HJ, Park TIH, Montgomery JM, Faull RLM, Dragunow M, Curtis MA. A method for generating high-yield enriched neuronal cultures from P19 embryonal carcinoma cells. J Neurosci Methods 2011;204:87-103.
38. Neher JJ, Neniskyte U, Zhao J-W, Bal-Price A, Tolkovsky AM, Brown GC. Inhibition of Microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J Immunol 2011;186:4973-4983.
39. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314-1318.
40. Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA, Tenen DG. The protooncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 1993;268:5014-5020.
41. Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010;120:277-286.
42. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-a-PU.1 pathway. Nat Med 2010;17:64-70.
43. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. Microglia and inflammatory mechanisms in the clearance of amyloid β peptide. Glia 2002;40:260-269.
44. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011;11:775-787.
45. Smith AM, Gibbons HM, Dragunow M. Valproic acid enhances microglial phagocytosis of amyloid-b1-42. Neuroscience 2010;169:505-515.
46. Streit WJ. Microglial senescence: Does the brain's immune system have an expiration date?Trends Neurosci 2006;29:506-510.
47. Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007;130:1759-1766.
48. Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RLM. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protocols 2007;1:2719-2732.
49. Walton MR, Gibbons H, MacGibbon GA, Sirimanne E, Saura J, Gluckman PD, Dragunow M. PU.1 expression in microglia. J Neuroimmunol 2000;104:109-115.
50. Wang X, Scott E, Sawyers CL, Friedman AD. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood 1999;94:560-571.
51. Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJM, Birkenhager TK, Bergink V, Drexhage HA. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behav Immun 2011;25:1162-1169.
52. Weigelt K, Ernst W, Walczak Y, Ebert S, Loenhardt T, Klug M, Rehli M, Weber BHF, Langmann T. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation. J Leuk Biol 2007;82:1564-1574.
53. Weigelt K, Lichtinger M, Rehli M, Langmann T. Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem Biophys Res Commun 2009;380:308-312.
54. Wilkinson NC, Navarro J. PU.1 regulates the CXCR1 promoter. J Biol Chem 1999;274:438-443.
55. Yang T, Zhou D, Stefan H. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: Uncontrolled inflammation drives disease progression? J Neurol Sci 2010;296:1-6.
56. Yeamans C, Wang D, Paz-Priel I, Torbett BE, Tenen DG, Friedman AD. C/EBP alpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 2007;110:3136-3142.
57. Zhang DE, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage-colony-stimulating factor receptor. Mol Cell Biol 1994;14:373-381.